Clinical trial
Feasibility of Semaglutide in Advanced Lung Disease
NCT05746039
Study timeline
Study start (actual)2024-01-29Date precision: day
Registry last updated2026-04-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesityunresolved
Interstitial Lung Diseaseunresolved
Chronic Obstructive Pulmonary Diseaseunresolved
Sarcoidosis, Pulmonaryunresolved
Pulmonary Hypertensionunresolved
Interventions
Semaglutide Pen InjectorDRUG · verified · RxNorm: semaglutide Pen Injector
Sponsors & collaborators
University of Pennsylvanialead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05746039 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.